Stay updated on Nivolumab and Metformin in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Metformin in Lung Cancer Clinical Trial page.

Latest updates to the Nivolumab and Metformin in Lung Cancer Clinical Trial page
- Check5 days agoChange DetectedThe page’s visible revision/version indicator was updated from v3.5.2 to v3.5.3, indicating a change in the ClinicalTrials.gov page revision rather than any study details.SummaryDifference0.0%

- Check12 days agoChange DetectedRevision: v3.5.2 added; Revision: v3.5.0 removed.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check41 days agoChange DetectedRevision label updated to v3.5.0, replacing the previous v3.4.3. This is an administrative metadata update.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check76 days agoChange DetectedAdded Revision: v3.4.2. Removed the prior notice about government funding lapse and the operating-status details (Revision: v3.4.1). These changes are administrative and do not affect study data or user actions on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check83 days agoChange DetectedAdded a site-wide government funding notice with links to cc.nih.gov and opm.gov; updated page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Nivolumab and Metformin in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Metformin in Lung Cancer Clinical Trial page.